Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

12871 ARTÍCULOS , VIENDO DEL 2026 AL 2040

Regulation of ATR-CHK1 signaling by ubiquitination of CLASPIN

Zhu X, Zheng XY, Gong P, Xu X.

Biochem Soc Trans. 2022 Oct 31;50(5):1471-1480. doi: 10.1042/BST20220729.

The genetic and molecular features of the intronic pentanucleotide repeat expansion in spinocerebellar ataxia type 10

Kurosaki T, Ashizawa T.

Front Genet. 2022 Sep 15;13:936869. doi: 10.3389/fgene.2022.936869. eCollection 2022.

Infantile Neuroaxonal Dystrophy in Two Cases: Siblings with Different Presentations

Ansari B, Nasiri J, Namazi H, Sedghi M, Afzali M.

Iran J Child Neurol. 2022 Summer;16(3):193-198. doi: 10.22037/ijcn.v16i2.30864. Epub 2022 Jul 16.

[Miller Fisher syndrome]

Andreasen AM, Guzmán-Martín A.

Ugeskr Laeger. 2022 Sep 26;184(39):V05220339.

Moyamoya associated with Turner syndrome in a patient with type 2 spinocerebellar ataxia-Occam's razor or Hickam's dictum: a case report

Nóbrega PR, da Costa FBS, Rodrigues PGB, de Maria Frota Vasconcelos T, Soares DMB, Araújo JS, Dias DA, Sobreira-Neto MA, de Paiva ARB, Braga-Neto P, Kok F, Fontenele EGP.

BMC Neurol. 2022 Oct 8;22(1):381. doi: 10.1186/s12883-022-02912-x.

Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy

Liu L, Chen J, Zhang Y, Wu J, Hu J, Lin Z.

Front Immunol. 2022 Sep 21;13:986018. doi: 10.3389/fimmu.2022.986018. eCollection 2022.

Case report: Thirty-year progression of an EMPF1 encephalopathy due to defective mitochondrial and peroxisomal fission caused by a novel de novo heterozygous DNM1L variant

Lhuissier C, Wagner BE, Vincent A, Garraux G, Hougrand O, Van Coster R, Benoit V, Karadurmus D, Lenaers G, Gueguen N, Chevrollier A, Maystadt I.

Front Neurol. 2022 Sep 23;13:937885. doi: 10.3389/fneur.2022.937885. eCollection 2022.

DDOST-CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype

Elsharkawi I, Wongkittichote P, Daniel EJP, Starosta RT, Ueda K, Ng BG, Freeze HH, He M, Shinawi M.

J Inherit Metab Dis. 2023 Jan;46(1):92-100. doi: 10.1002/jimd.12565. Epub 2022 Oct 17.

The Neuroprotective Potential of Endophytic Fungi and Proposed Molecular Mechanism: A Current Update

Semwal P, Painuli S, Anand J, Martins NC, Machado M, Sharma R, Batiha GE, Yaro CA, Lorenzo JM, Rahman MM.

Evid Based Complement Alternat Med. 2022 Oct 1;2022:6214264. doi: 10.1155/2022/6214264. eCollection 2022.

A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report

Lebredonchel E, Riquet A, Neut D, Broly F, Matthijs G, Klein A, Foulquier F.

Ital J Pediatr. 2022 Oct 11;48(1):178. doi: 10.1186/s13052-022-01355-x.

Neurodegenerative Cerebellar Ataxia

Rosenthal LS.

Continuum (Minneap Minn). 2022 Oct 1;28(5):1409-1434. doi: 10.1212/CON.0000000000001180.

Intramedullary Nail and Plate Combination Technique for Peri-Implant Both-Bone Forearm Fractures

Jacobs RC, Schmitz MW, Swiontkowski MF.

Cureus. 2022 Sep 6;14(9):e28828. doi: 10.7759/cureus.28828. eCollection 2022 Sep.

A Rare Phenotype of Inherited Cerebellar Ataxia

Raval DM, Rathod VM, Dobariya RK, Dave MP, Patel NS.

Cureus. 2022 Sep 6;14(9):e28831. doi: 10.7759/cureus.28831. eCollection 2022 Sep.

Recent developments in the design and synthesis of benzylpyridinium salts: Mimicking donepezil hydrochloride in the treatment of Alzheimer's disease

Sepehri S, Saeedi M, Larijani B, Mahdavi M.

Front Chem. 2022 Sep 26;10:936240. doi: 10.3389/fchem.2022.936240. eCollection 2022.

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

Deng S, Vlatkovic T, Li M, Zhan T, Veldwijk MR, Herskind C.

Cancers (Basel). 2022 Oct 5;14(19):4874. doi: 10.3390/cancers14194874.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias